283 related articles for article (PubMed ID: 21616002)
1. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
[No Abstract] [Full Text] [Related]
2. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
Sun LM; Qiu XS; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
[No Abstract] [Full Text] [Related]
3. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
[No Abstract] [Full Text] [Related]
4. [Standardization in diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms: the Chinese consensus].
Chinese pathologic consensus group for gastrointestinal and pancreatic neuroendocrine neoplasms
Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):691-4. PubMed ID: 24439254
[No Abstract] [Full Text] [Related]
5. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
[TBL] [Abstract][Full Text] [Related]
6. Synaptophysin-Ki67 double stain: a novel technique that improves interobserver agreement in the grading of well-differentiated gastrointestinal neuroendocrine tumors.
Matsukuma K; Olson KA; Gui D; Gandour-Edwards R; Li Y; Beckett L
Mod Pathol; 2017 Apr; 30(4):620-629. PubMed ID: 28084345
[TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of metastasis‑related risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features.
Tang C; Gong L; Zou W; Zhang J; Zhou Y; Wu X; Lu F; Ouyang C; Liu X
Oncol Rep; 2016 Dec; 36(6):3343-3352. PubMed ID: 27748940
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
Milione M
Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
[No Abstract] [Full Text] [Related]
10. Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum.
Ikeda K; Kojima M; Saito N; Sakuyama N; Koushi K; Watanabe T; Sugihara K; Akimoto T; Ito M; Ochiai A
Pathol Int; 2016 Feb; 66(2):94-101. PubMed ID: 26814047
[TBL] [Abstract][Full Text] [Related]
11. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm].
Bao F; Chen GR; Hui P; Cai GP
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):426-32. PubMed ID: 24060085
[No Abstract] [Full Text] [Related]
14. [WHO classification of pancreatic neuroendocrine tumor: overview].
Sasano H; Yazdani S; Kasajima A
Nihon Rinsho; 2015 Mar; 73 Suppl 3():321-6. PubMed ID: 25857041
[No Abstract] [Full Text] [Related]
15. INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas.
McHugh KE; Mukhopadhyay S; Doxtader EE; Lanigan C; Allende DS
Am J Clin Pathol; 2020 May; 153(6):811-820. PubMed ID: 32128564
[TBL] [Abstract][Full Text] [Related]
16. Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors.
Tomita T
Bosn J Basic Med Sci; 2020 Aug; 20(3):336-346. PubMed ID: 32020844
[TBL] [Abstract][Full Text] [Related]
17. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
[TBL] [Abstract][Full Text] [Related]
18. [The new classification of neuroendocrine tumors from the clinical viewpoint].
Schürmann G; Senninger H
Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Pancreatic Neuroendocrine Tumor Recurrence and Survival Predicted by Ki67.
Nieveen van Dijkum EJM
Ann Surg Oncol; 2019 Dec; 26(Suppl 3):531-532. PubMed ID: 30519760
[No Abstract] [Full Text] [Related]
20. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
